[A proposed guideline for economic evaluation of health technologies].
Over the last few years, economic evaluation of health technologies has become a major tool used by European health policy decision-makers to create strategies for prioritizing the allocation of health resources and the approval of new technologies. Spain was a pioneer in proposing the standardization of methodology applicable to economic evaluation studies. However, because health policy decision-makers refused to support the initiative, the methodology was never put into practice. In the medium term, evidence of the economic value of new health technologies financed by the national health system will probably be increasingly required. At that time, stakeholders and decision-makers will have to agree upon a clear and concise set of rules on the technical and methodological issues that must be followed by economic evaluations of health technologies. Consequently, we have provided guidelines and recommendations for producing first-rate economic evaluations. The recommendations appear under seventeen headings or sections. In each case, the recommended requirements to be satisfied by an economic evaluation of health technologies are provided and each recommendation is followed by a commentary, providing a justification and comparing and contrasting the proposal with other available alternatives.
López Bastida
Julio
J
Servicio Canario de Salud, Unidad de Planificación y Evaluación, Santa Cruz de Tenerife, Spain.
Oliva
Juan
J
Antoñanzas
Fernando
F
García-Altés
Anna
A
Gisbert
Ramón
R
Mar
Javier
J
Puig-Junoy
Jaume
J
D020811:Biomedical Technology / Q000191:economics*; D003365:Costs and Cost Analysis; D017408:Guidelines as Topic